Filters

NRF-1 Antibody, Cy7 Conjugated

NRF-1 Antibody, Cy7 Conjugated size: 0.1ml 350

Price 350
Size 0.1ml
Long name Cy7 Conjugated, NRF-1 Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenNRF-1
SpecificityThis is a highly specific antibody against NRF-1
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range80-116/503
Subcellular locationNucleus
SourceKLH conjugated synthetic peptide derived from human NRF1
Gene ID number4899
Swiss ProtQ16656
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background Implicated in the control of nuclear genes required for respiration, Links the transcriptional modulation of key metabolic genes to cellular growth and development, and mitochondrial DNA transcription and replication, heme biosynthesis, Transcription factor that activates the expression of the EIF2S1 (EIF2-alpha) gene
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
Synonyms Alpha palindromic-binding protein, NRF-1, NRF1, Nuclear respiratory factor 1, ALPHA-PAL
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetNRF-1 Conjugated
Short name Conjugated, NRF-1 Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, NRF-1 (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter